Albert Robichaud

Chief Scientific Officer, Sage Therapeutics, Inc.

Companies

Sage Therapeutics, Inc.Chief Scientific Officer Jul 17, 2014 to Feb 15, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Sage Therapeutics, Inc.145,553 shares²Feb 3, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 3, 2023Shares withheld for tax 1,127 shares at $44.16 of Sage Therapeutics, Inc.²
Feb 3, 2023Granted 3,375 shares of Sage Therapeutics, Inc.²
Oct 19, 2021Shares withheld for tax 1,116 shares at $40.29 of Sage Therapeutics, Inc.³
Oct 19, 2021Granted 3,800 shares of Sage Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSage Therapeutics, Inc., Chief Scientific Officer
2
SEC EDGARSage Therapeutics, Inc. shares after the filing of Feb 3, 2023
3
SEC EDGARForm 4 filed Oct 21, 2021